ImmunologybioRxivPreprint
Generation and therapeutic efficacy of the novel Fc-modified cross-neutralizing human monoclonal antibodies against dengue virus
S. Injampa, S. Benjathummarak, S. Keadsanti…·P. Pitaksajjakul
This paper develops two Fc-modified human monoclonal antibodies that neutralize all dengue virus serotypes without causing antibody-dependent enhancement or complement activation.
DOI 10.1101/2023.05.25.542225